Nerve stimulation therapy has shown promise in the treatment of spinal cord injuries in animal models. Researchers hope the treatment will be used in humans with SCI to help restore movement to limbs.
Somatosensory feedback from specialized sensors helps inform the spinal cord about ongoing movement and keeps a cat from falling when they encounter obstacles.
High-frequency repetitive transcranial magnetic stimulation (rTMS) activates MAP2K signaling and enhanced axon regeneration and functional recovery following spinal cord injury.
Axicabtagene ciloleucel (axi-cel), a form of CAR-T therapy appears to be safe and has encouraging signs of efficacy in treating both lymphoma of the brain and spinal cord injury.
A new hybrid of biomaterial nanoparticles in conjunction with existing methods of tissue regeneration was successfully synthesized to promote and regenerate tissue following spinal cord injury. The new method has the potential to treat spinal cord injuries.
Vsx2 neurons are vital and sufficient for spinal cord stimulation therapies to be effective to restore motor function in those with spinal cord injury and for nerve fiber reorganization.
Intensive physical therapy in tandem with neural stem cell grafts increases tissue growth, repair, and functionality more than using the treatments alone for spinal cord injuries.
Using zebrafish, researchers investigated the timing and genetic programming of macrophages that help repair and regenerate the sensory organs within the fish. The findings could help pave the way for regenerative treatments for spinal cord injuries, hearing loss, and heart disorders in humans.
Researchers have created a new blueprint that outlines how embryonic stem cells from mice become sensory interneurons and identified a method for producing sensory interneurons in a lab setting. If the results can be replicated in human stem cells, researchers say the findings could contribute to the development of therapies to restore sensation to those suffering nerve damage and spinal cord injury.
A brain-penetrating experimental drug in development as a cancer treatment can foster the regeneration of damaged nerves following spinal cord injury, researchers report.
A new injectable therapy that uses specially engineered molecules could help treat spinal cord injury.